Image

Impact of Early Ventilation in Stroke Outcomes in Patients With Sleep Apnea After First Ever Stroke

Impact of Early Ventilation in Stroke Outcomes in Patients With Sleep Apnea After First Ever Stroke

Recruiting
18-80 years
All
Phase 2

Powered by AI

Overview

To evaluate the impact of early ventilation in stroke outcomes in patients with sleep apnea and first ever stroke, 1 month after stroke.

Description

Single-center, randomized, open label, parallel arm, prospective study in patients with sleep apnea after first-ever stroke.

The study will consist of screening, baseline assessment, interventional period (consisting of a treatment period and follow-up visits), and a follow-up phone call.

Patients will be randomly assigned to ASV (active) or control groups, within 4 days after the PSG II and will start the respective intervention in the same day.

Patients assigned to the active group will receive ventilatory support with ASV (DreamStation BiPAP autoSV®) during diurnal and nocturnal sleep, from study randomization until clinically indicated. Patients assigned to control group will receive best medical treatment for stroke alone, including rehabilitation.

Eligibility

Inclusion Criteria:

  1. Written informed consent obtained from the participant or the legally acceptable representative, prior to any study-related procedure.
  2. Male or female between 18 and 80 years, inclusive, at the time of signing the informed consent.
  3. Admission to the hospital within 48 h of stroke symptoms onset.
  4. Ischemic first stroke diagnosis.
  5. NIHSS ≥2 at screening.
  6. Sleep apnea with AHI ≥15.

Exclusion Criteria:

  1. CSA with Left Ventricular Ejection Fraction ⩽45%.
  2. Ventilation treatment for sleep apnea diagnosis, prior to stroke.
  3. Risk of aspiration.
  4. Nasogastric feeding tube.
  5. Transient ischemic attack, hemorrhagic stroke or subarachnoid hemorrhage.
  6. Stroke due to a secondary cause (e.g. vascular malformation, vasculitis, brain tumor, head trauma, or predisposition to bleeding).
  7. Cardiorespiratory distress.
  8. Advanced chronic lung disease requiring supplemental oxygen.
  9. Concomitant central nervous system diseases such as dementia or multiple sclerosis.
  10. Uncontrolled psychosis or agitation.
  11. Glasgow Coma Scale (GCS) score <10 at screening.
  12. Anosognosia, global or Wernicke aphasia.
  13. Insufficient upper limbs function to use a mask and no overnight caregiver to help.
  14. Inability to attend to the rehabilitation program of the hospital.
  15. Pregnant and breast-feeding women.
  16. Participation in another clinical study (except a standard-of-care registry).
  17. Any other condition that, according to the Investigator, renders the subject unsuitable for ventilation.

Study details
    Stroke
    Sleep Apnea

NCT04903951

Philips Portuguesa S.A.

14 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.